Georgia State University

ScholarWorks @ Georgia State University
Public Health Theses

School of Public Health

Summer 8-12-2014

A Comparison of Anthropometric Measures for Classification of
Metabolic Syndrome and Cardiometabolic Risk Factors, NHANES
2007-2010
John Heath

Follow this and additional works at: https://scholarworks.gsu.edu/iph_theses

Recommended Citation
Heath, John, "A Comparison of Anthropometric Measures for Classification of Metabolic Syndrome and
Cardiometabolic Risk Factors, NHANES 2007-2010." Thesis, Georgia State University, 2014.
doi: https://doi.org/10.57709/5855554

This Thesis is brought to you for free and open access by the School of Public Health at ScholarWorks @ Georgia
State University. It has been accepted for inclusion in Public Health Theses by an authorized administrator of
ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu.

ABSTRACT

BACKGROUND: Type 2 diabetes and cardiovascular disease (CVD) are among the leading
causes of death in the United States. The Metabolic Syndrome, which comprises a cluster of
cardiometabolic risk factors, puts individuals at increased risk for these diseases. It is therefore
important that people with Metabolic Syndrome, at high risk for CVD and type 2 diabetes, are
identified and treated. Since it may not often be practical to obtain the laboratory measures
necessary for diagnosing the Metabolic Syndrome, simple anthropometric measures are a useful
way of quickly identifying individuals at increased risk for the Metabolic Syndrome.
OBJECTIVE: The purpose of this thesis is to evaluate the utility of three of the most
commonly used anthropometric measures – Body Mass Index (BMI), Waist Circumference
(WC), and Waist-to-Height Ratio (WC) – for classifying individuals with and without the
Metabolic Syndrome and its component risk factors in the United States. Using Receiver
Operating Characteristic (ROC) curve analysis and Area Under the Curve (AUC) statistics, this
thesis will assess the utility of each body measurement and compare it to BMI.
METHODS: A large, multi-ethnic, nationally representative sample from the National Health
and Nutrition Examination Survey (NHANES) 2007-2010 was used for this analysis. The study
sample was restricted to adults aged 20-65 with complete information on height, weight, waist
circumference, blood pressure, HDL cholesterol, fasting glucose, and triglycerides (n=3,769). In
order to compare the utility of different anthropometric measures for classification, weighted
ROC curves were constructed for each anthropometric measure-outcome combination and AUC
statistics were compared. AUC statistics were calculated by approximating the definite integral
of the ROC curves with the trapezoidal rule. Variances for AUC statistics and differences in
AUC statistics were estimated with jackknife repeated replication. Analyses were completed for
the entire sample and separately for non-Hispanic whites, non-Hispanic blacks, and Mexican
Americans.
RESULTS: For the entire sample, WC (AUC=0.752) did a better job than BMI (AUC=0.728)
at classifying individuals with and without the Metabolic Syndrome (p<0.001) and all of the
component risk factors except for HDL cholesterol. WHtR (AUC=0.740) performed better than
BMI at classifying the Metabolic Syndrome (p=0.048), high blood pressure, and high
triglycerides. The performance of WHtR was inconsistent across race. For every analysis in the
overall sample and in the race subgroups, WC performed significantly better than BMI or no
different from BMI, except for low HDL cholesterol among Mexican Americans where it
performed significantly worse than BMI.
CONCLUSION: Waist circumference should be considered, especially over BMI, for risk
stratification in clinical settings and research. Further research should attempt to identify
optimum waist circumference cut points for use in the US population.
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Chapter I
INTRODUCTION

1.1 Background
Type 2 diabetes and cardiovascular disease (CVD) are among the leading causes of death
in the United States (Murphy, Xu, & Kochanek, 2013; CDC, 2014). The Metabolic Syndrome,
which comprises a cluster of cardiometabolic risk factors, puts individuals at increased risk for
these diseases (Ford, Li, & Sattar, 2008; Gami et al., 2007). It is therefore important that people
with Metabolic Syndrome, at high risk for CVD and type 2 diabetes, are identified and treated.
Since it may not often be practical to obtain the laboratory measures necessary for diagnosing the
Metabolic Syndrome, simple anthropometric measures are a useful way of quickly identifying
individuals at increased risk for the Metabolic Syndrome and thus type 2 diabetes and CVD.

1.2 Study Purpose
The purpose of this thesis is to evaluate the utility of three of the most commonly used
anthropometric measures – Body Mass Index (BMI), Waist Circumference (WC), and Waist-toHeight Ratio (WHtR) – for classifying individuals with and without the Metabolic Syndrome and
its component risk factors. Using Receiver Operating Characteristic (ROC) curve analysis and
Area Under the Curve (AUC) statistics, this thesis will assess the absolute utility of each body
measurement and compare it to BMI which may be considered the gold standard for
anthropometric measures.
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Chapter II
REVIEW OF LITERATURE

2.1 Cardiovascular Disease, Type II Diabetes Mellitus, and the Metabolic Syndrome
CVD is the leading cause of death for both men and women in the United States, killing
about 600,000 people every year (Murphy et al., 2013). The cost of health care services,
medications, and lost productivity related to CVD in the US each year totals $108 billion
(Heidenreich et al., 2011). In the US, morbidity and mortality related to CVD is highest among
non-Hispanic blacks (CDC, 2005; Bauer, Briss, Goodman, & Bowman, 2014) and projections
have indicated that this disparity will continue into the future (Heidenreich et al., 2011).
Type 2 diabetes was the seventh leading cause of death in the United States in 2010 and
was listed as the underlying cause of death on 69,071 death certificates and mentioned as a cause
of death on a total of 234,051 death certificates. Another 29.1 million people, or 9.3% of the
United States population, are thought to be currently living with diabetes, 8.1 million of which
are unaware of their diabetic status (CDC, 2014). Diabetes cost the United States $245 billion in
direct and indirect medical costs in 2012 (CDC, 2014). Type 2 diabetes was previously referred
to as adult-onset diabetes and is distinguished from type 1 diabetes, which was previously
referred to as juvenile-onset diabetes. It’s estimated that type 2 diabetes accounts for 90% to
95% of all diagnosed cases of diabetes (CDC, 2014). For the purposes of this thesis the term
‘diabetes’ will refer only to type 2 diabetes.
The prevalence of diabetes remained fairly constant in the US from 1980 through 1990
but has steadily increased since 1990 (CDC, 2012). The US also saw a dramatic nationwide
increase in obesity between 1990 and 2010 (CDC, 2014). In 2010, it was projected that by 2050
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as many as 1 in 3 adults in the United States could have diabetes if the current trend continues
unabated (Boyle, Thompson, Gregg, Barker, & Williamson, 2010). There are also significant
racial disparities in diabetes morbidity. From 2010 to 2012 in the United States it was estimated
that among people aged 20 years or older, 13.2 % of non-Hispanic blacks and 12.8% of
Hispanics had diagnosed diabetes compare to 7.6% of non-Hispanic whites; American Indians
and Alaska Natives had the highest prevalence at 15.9% (CDC, 2014).
CVD and diabetes share a number of individual risk factors, including high blood
pressure, dyslipidemia, and obesity (Smith, 2007). Increased fasting glucose is essentially the
definition of prediabetes (CDC, 2014). Together, these risk factors – high blood pressure,
dyslipidemia, increased fasting glucose, and obesity – compose the Metabolic Syndrome as it is
currently defined by the International Diabetes Foundation (Alberti et al., 2009).
The concept of the Metabolic Syndrome was first proposed by Gerald Reaven in 1988
(Reaven, 1988). He termed it Syndrome X and implicated insulin resistance as the underlying
cause. It was subsequently called many other things, but is now most commonly referred to as
the Metabolic Syndrome. There has been much debate over the underlying cause of the
Metabolic Syndrome. Earlier studies implicated insulin resistance (Ferrannini, Haffner,
Mitchell, & Stern, 1991; Reaven, 1988), but more recently focus has turned to visceral,
abdominal obesity and has shown it to be an independent predictor of insulin resistance as well
as the other features of the Metabolic Syndrome (Carr et al., 2004; Wagenknecht et al., 2003).
Determining the underlying cause of the Metabolic Syndrome is beyond the scope of this
thesis. It is generally agreed, however, that the Metabolic Syndrome is a clustering of
interrelated metabolic risk factors that increase the risk of CVD and diabetes and that it increases
the risk of diabetes more than it increases the risk of CVD (Ford et al., 2008; Gami et al., 2007).
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Getting a clear picture of exactly how much the Metabolic Syndrome increases the risk for CVD
and diabetes can be difficult as studies are often conducted among very different populations,
using different diagnostic criteria, and with different outcomes of interest. However, metaanalyses have indicated that Metabolic Syndrome is associated with approximately 1.5 to 2 times
the risk of incident CVD and CVD related death, even after controlling for traditional
cardiovascular risk factors (Galassi, Reynolds, & He, 2006; Gami et al., 2007). The degree to
which the Metabolic Syndrome increases the risk for diabetes depends on how many components
of the syndrome an individual has. Risk increases with the number of components present and it
has been shown that having 3 or 4 components of the Metabolic Syndrome may increase the risk
for incident diabetes by over 10 or 20 times, depending on the combination of risk factors (Ford
et al., 2008; Wilson, D’Agostino, Parise, Sullivan, & Meigs, 2005). Meta-analyses and other
studies indicate that the Metabolic Syndrome increases the risk of incident diabetes by 3 to 7
times, and that this increase in risk is independent of other risk factors such as fasting insulin
(Aschner, 2010; Ford et al., 2008; Hanley et al., 2005; Lorenzo et al., 2003). It was estimated
that between 2003 and 2006 approximately 34% of adults 20 years of age and over had the
Metabolic Syndrome; non-Hispanic black males were about half as likely to have the Metabolic
Syndrome as non-Hispanic white males and non-Hispanic black and Mexican American females
were about 1.5 times as likely to have the Metabolic Syndrome as non-Hispanic white females
(Ervin, 2009).
The components of the Metabolic Syndrome – abdominal obesity, high blood pressure,
low HDL cholesterol, high triglycerides, and high fasting glucose – are all cardiometabolic risk
factors on their own and it has been suggested that the predictive ability of the Metabolic
Syndrome for CVD and diabetes represents little more than the sum of its parts (Cameron et al.,
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2007; Ford et al., 2008). However, Cameron et al. (2007) conducted their study with a sample of
about 3,000 Mauritians, a population with relatively low waist circumference, and found that the
waist circumference cut points for 2 of the 3 definitions of Metabolic Syndrome that they used
did not perform well in that population. The third definition of Metabolic Syndrome used waistto-hip ratio instead of waist circumference to define abdominal obesity, and using this definition
the researchers did indeed find that individuals with the Metabolic Syndrome were at a 2 fold
increased risk for diabetes, even when controlling for all the individual components of the
Metabolic Syndrome.
The Metabolic Syndrome is of interest primarily because it helps to identify individuals
who are at increased risk of both type 2 diabetes and CVD, despite whether it is more predictive
of CVD and diabetes than the sum of its parts or it is simply a collection of cardiometabolic risk
factors that tend to present together and confer additive risks to an individual. It is therefore
important that individuals with this cluster of risk factors be identified for intervention and
treatment. Several organizations have proposed diagnostic criteria for identifying these
individuals.

2.2 Diagnostic Criteria for the Metabolic Syndrome
The first proposed diagnostic criteria came from the World Health Organization (WHO)
and emphasized evidence of insulin resistance as a requirement for diagnosis of the Metabolic
Syndrome (Alberti & Zimmet, 1998). The WHO criteria required an individual have insulin
resistance plus two additional risk factors – obesity, hypertension, high triglycerides or reduced
HDL cholesterol. In 2001, the National Cholesterol Education Program (NCEP) Adult
Treatment Panel III (ATP III) released its own criteria for defining the Metabolic Syndrome
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(NCEP ATP III, 2002). The ATP criteria did not require insulin resistance or any other single
risk factor as necessary for diagnosis of the Metabolic Syndrome. Instead, NCEP suggested that
the presence of 3 out of 5 risk factors – abdominal obesity, elevated triglycerides, low HDL
cholesterol, elevated blood pressure, and elevated fasting glucose – be the basis for the diagnosis
of Metabolic Syndrome. These risk factors were chosen as the basis for diagnosis because they
were the components of Metabolic Syndrome that can most readily be measured through routine
clinical evaluation, unlike insulin resistance and a proinflammatory state.
In 2005, the International Diabetes Federation (IDF) and the American Heart
Association/National Heart, Lung, and Blood Institute (AHA/NHLBA) met to try to reconcile
the different diagnostic criteria for the Metabolic Syndrome (Alberti, Zimmet, Shaw, & IDF
Epidemiology Task Force Consensus Group, 2005). However, the recommendations that
emerged from that meeting were still conflicting. The IDF agreed with the ATP III
recommendations that insulin resistance not be required for a diagnosis, but recommended
instead that abdominal obesity be required as 1 of 5 risk factors with the remaining four risk
factors largely unchanged from the ATP III definitions. Under this definition, abdominal obesity
plus 2 or more of the remaining 4 risk factors would constitute a diagnosis of Metabolic
Syndrome. The IDF also suggested that waist circumference may provide a simple and useful
screening tool for Metabolic Syndrome. The AHA/NHLBI recommendations were similar but
did not require abdominal obesity for diagnosis. These organizations recently met again and
agreed that waist circumference should not be required for diagnosis (Alberti et al., 2009).
Therefore, the presence of 3 or more of 5 risk factors – abdominal obesity, high blood pressure,
low HDL cholesterol, high triglycerides, and high fasting glucose – constitute one of the most
recent and widely used definitions of Metabolic Syndrome. These recommendations also
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include clinical cut points for determining whether each risk factor can be considered present in
an individual. These cut points are displayed in Table 1 and are the cut points used for the
purposes of this thesis. It has been pointed out that the 5 variables in this definition are not used
as continuous variables but instead as risk factors that are either present or absent, which makes
it a less than perfect tool for diagnosis; they cannot be used in the sort of risk calculator for CVD
or diabetes that treats the variables continuously (Després et al., 2008).

Table 1. Criteria for Metabolic Syndrome Diagnosis
Measure
Cut Points
Elevated waist circumference

Population specific
cut points

High Blood Pressure

Systolic ≥ 130 and/or
diastolic ≥ 85 mm Hg

Low HDL Cholesterol

<40 mg/dL in males;
<50 mg/dL in females

High Triglycerides

≥ 150 mg/dL

High Fasting Glucose

≥ 100 mg/dL

Criteria from (Alberti et al., 2009)

2.3 Anthropometric Measures for Risk Classification
It has long been known that obesity is associated with the risk factors that compose the
Metabolic Syndrome, though it has been debated whether they are more closely associated with
total absolute fat or abdominal obesity in particular (Kannel et al., 1991). Total absolute fat is
most often assessed by Body Mass Index (BMI), whereas abdominal fat is most often assessed
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with Waist Circumference (WC). Waist-to-height ratio (WHtR) has also been proposed as a
measure of obesity that takes the bodily distribution of fat into account in a way that BMI does
not. All three of these measures have been proposed as simple screening tools to identify
individuals that may be at increased risk for the Metabolic Syndrome, its component risk factors,
CVD, diabetes, or mortality. BMI has emerged as the measure most commonly used. Much
work has been done to determine which body measurement is the most useful predictor
(Ashwell, Gunn, & Gibson, 2012; Christian, Mochari, & Mosca, 2009; Czernichow, Kengne,
Stamatakis, Hamer, & Batty, 2011; Huxley, Mendis, Zheleznyakov, Reddy, & Chan, 2010; Lee,
Huxley, Wildman, & Woodward, 2008; van Dijk, Takken, Prinsen, & Wittink, 2012; Vazquez,
Duval, Jacobs, & Silventoinen, 2007), although it is difficult to get a clear picture of which
measurements perform best due to the varying methods and study populations. It has been
demonstrated that the relationship between these anthropometric indices and cardiometabolic
risk factors varies by race (Christian et al., 2009), which makes meta-analyses that include data
from several different populations difficult to interpret.
A meta-analysis of over 82,000 British individuals from 9 cohorts found that greater WC
was associated with increased risk of CVD mortality after controlling for traditional
cardiometabolic risk factors and that BMI was not (Czernichow et al., 2011). Another metaanalysis that focused solely on the outcome of incident diabetes (Vazquez et al., 2007) analyzed
data from 32 studies from around the world and found that the relative risks for incident diabetes
were essentially the same for BMI and WC. However, other research has indicated that
abdominal obesity is more important to the development of diabetes and suggests that WC is a
stronger predictor of diabetes than BMI (Klein et al., 2007).
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Yet another meta-analysis of 20 articles with data on over 45,000 European and US
Caucasian men and women found that WC correlated more highly with blood pressure,
triglycerides, and fasting blood glucose than did BMI or WHtR; for HDL cholesterol, the
correlation with WC was about the same as BMI and both were more highly correlated than
WHtR (Van Dijk et al., 2012). The authors therefore suggested that WC be used in clinical
practice and research studies above BMI.
Perhaps most relevant to this thesis due to the similar research questions, outcomes, and
methods of the studies included, Ashwell et al. (2012) conducted a meta-analysis of 31 primary
studies from all over the world that used ROC curve analysis to compare the utility of WHtR
against either BMI or WC in classifying individuals with diabetes, hypertension, and
dyslipidemia, among other outcomes. They found that for all outcomes WHtR improved
classification over BMI by 4-5% and that WC improved classification over BMI by 3%. This
meta-analysis evaluated many of the same studies as an earlier meta-analysis by Lee et al. (2008)
that reached similar conclusions. The authors therefore recommended that WHtR be considered
as a screening tool before BMI and WC, as has been suggested before (Ashwell & Hsieh, 2005).

Chapter III
METHODS

3.1 Study Purpose
The purpose of this thesis is to determine which anthropometric measure – BMI, WC, or
WHtR – is the best discriminator for detecting individuals with the Metabolic Syndrome and its
components – high blood pressure, low HDL cholesterol, high triglycerides, and high fasting
glucose – in a large, nationally representative, and multi-ethnic sample of adults in the United
States.

3.2 Data Source
Data were obtained from the 2007-2008 and 2009-2010 cycles of the National Health and
Nutrition Examination Survey (NHANES), a program of the National Center for Health
Statistics. NHANES utilizes a large, multi-stage probability sample design to facilitate
nationally representative estimates and collects data through a questionnaire, a physical
examination, and laboratory testing. It is therefore used to set US national standards for
measurements such as weight and blood pressure. This thesis uses data from the questionnaire,
examination, and laboratory components of NHANES. Health interviews are conducted in
respondents’ homes while the examination and laboratory components are conducted is a mobile
examination center (MEC). All data is collected by trained personnel.
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3.3 Study Sample
From 2007-2010, NHANES collected data on 20,686 individuals. Only adults aged 2065 with complete information on height, weight, waist circumference, blood pressure, HDL
cholesterol, fasting glucose, and triglycerides were included in the sample for this thesis.

3.4 Variables
This thesis considered several anthropometric measures, all of which are continuous. The
outcomes were also continuous, but were dichotomized for the purposes of this thesis. For
example, each individual has a specific systolic blood pressure, but they have been dichotomized
for this thesis as either having high blood pressure or not having high blood pressure. The cut
points for the outcomes are clinical diagnosis criteria for the Metabolic Syndrome as proposed by
the International Diabetes Federation Task Force on Epidemiology and Prevention, the National
Heart, Lung, and Blood Institute, and the American Heart Association, among others (Alberti,
2009).

3.4.1 Body Mass Index (BMI)
Height and weight were recorded for each individual during the mobile examination
portion of the survey. Standing height was recorded in centimeters as each participant stood with
their heels together against a straight backboard. Participants were weighed in kilograms with a
digital scale while wearing only a standard gown and underpants. BMI was computed by
dividing a participant’s weight in kilograms by their height in meters squared.
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3.4.2 Waist Circumference (WC)
Waist circumference was measured in centimeters for each participant. Measurements
were taken just above the uppermost lateral border of the right ilium.

3.4.3 Waist to Height Ratio (WHtR)
Waist to height ratio was computed as waist circumference in centimeters divided by
standing height in centimeters.

3.4.4 High Blood Pressure
Systolic and diastolic blood pressure was recorded for participants 8 years and older
during the MEC portion of the survey. Both were measured after the participant sat and rested
quietly for 5 minutes. Three measurements were taken for both systolic and diastolic blood
pressure, and if one measurement was incomplete then a fourth measurement was taken. For this
thesis, an individual’s systolic and diastolic blood pressure was computed as the mean of all nonmissing measurements.
Individuals were classified as having high blood pressure if they met one of three criteria:
systolic blood pressure greater than or equal to 130, diastolic blood pressure greater than or equal
to 85, or if they’ve been told by a doctor that they have hypertension and are currently taking
medication to control their blood pressure. Individuals that did not meet one of these three
criteria were classified as not having high blood pressure.
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3.4.5 Low HDL Cholesterol (HDL)
HDL cholesterol was measured in mg/dL for all NHANES participants 6 years and older.
Blood was drawn and HDL levels were determined by Roche Modular P chemistry analyzer.
Males with HDL cholesterol less than 40 mg/dL and females with HDL cholesterol less
than 50 mg/dL were classified as having low HDL.

3.4.6 High Fasting Glucose
Fasting glucose was recorded in mg/dL for a subsample of NHANES participants 12
years and older that were examined during the morning MEC session. Eligible participants also
had to have fasted for at least 9 hours prior to examination. Blood was drawn and fasting
glucose levels were determined by Roche Modular P chemistry analyzer. Individuals that had
hemophilia, that were taking medication for diabetes, and that had not fasted for at least 9 hours
prior to the examination were excluded.
Individuals were classified as having high fasting glucose if they had fasting glucose
greater than or equal to 100 mg/dL or if they had been told by a doctor that they have diabetes or
prediabetes and reported currently taking medication to lower blood sugar.

3.4.7 High Triglycerides
Triglycerides were measured in mg/dL for a subsample of participants 12 years and older
that were examined during the morning MEC session. Blood was drawn and triglyceride levels
were determined by Roche Modular P chemistry analyzer.
Individuals were classified as having high triglycerides if they had triglycerides greater
than or equal to 150 mg/dL.
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3.4.8 Metabolic Syndrome
Under the definition used for this thesis (Alberti et al., 2009), the Metabolic Syndrome is
diagnosed on the basis of having 3 of the following 5 risk factors: abdominal obesity, high blood
pressure, low HDL, high fasting glucose, and high triglycerides. Since measures of obesity are
being used to classify individuals, the Metabolic Syndrome is defined here as having at least 2 of
the remaining 4 risk factors, similar to the old IDF definition before the requirement for
abdominal obesity was dropped (Alberti et al., 2005).

3.5 Statistical Analysis
In order to compare the utility of different anthropometric measures for classifying
individuals, each measure was considered as a screening test for the presence of the Metabolic
Syndrome and its component risk factors. For each of these tests empirical ROC curves were
constructed and AUC statistics were compared. Therefore, an ROC curve was constructed for
each body measurement-outcome combination. Sampling weights provided by NHANES were
used in the construction of the ROC curves. Individuals that were tested for fasting glucose and
triglycerides and that were required to fast before the MEC session were a smaller subsample of
the larger MEC sample, so unique sampling weights are provided for analyses restricted to that
subsample of individuals. The fasting subsample weights were used for all analyses in this
thesis.
Many standard statistical packages that construct ROC curves do not take into account
sampling weights. For this thesis, weighted contingency tables were constructed for each
relevant cut point of the body measurement. The weighted counts in these tables allowed for the
calculation of sensitivity and specificity at each cut point. The sensitivity was then plotted
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against 1-specificity to create the ROC curves. AUC statistics were calculated by approximating
the definite integral of the ROC curves with the trapezoidal rule.
Standard methods for estimating the variance of AUC statistics do not take into account
survey design or sampling weights. Variances for the AUC statistics and differences in AUC
statistics were estimated with jackknife repeated replication (Wolter, 2007). In a stratified
cluster design, jackknife repeated replication works by dropping out one primary sampling unit
(PSU) at a time and reweighting the remaining PSUs in that stratum. In a stratum with 2 PSUs,
the weights for one PSU will be set to zero and the weights for the other PSU will be multiplied
by 2. In a stratum with 3 PSUs, the weights for one PSU will be set to zero and the weights for
the others will be multiplied by 1.5. This process is repeated for each PSU, resulting in as many
replicates as there are PSUs in the sample. The sample for this thesis contained 63 PSUs. Thus,
63 replicates were constructed, each with its own set of weights. A separate estimate is then
produced for each replicate, resulting in 63 estimates. The variation in these estimates is the
basis for estimating the standard error of the statistic: the sum of the squared differences between
the full sample estimate of the statistic and each replicate estimate is divided by a factor that
depends on the number of PSUs in that stratum.
AUC statistics and 95% confidence intervals were calculated for each combination of
body measurement and risk factor. Within each risk factor, the AUC statistics for each body
measurement were compared to the AUC statistic for BMI, which was the reference, by
subtracting the AUC for BMI from the AUC for each other measurement. Thus, a negative
difference indicates that BMI had a larger AUC statistic and a positive difference indicates that
BMI had a smaller AUC statistic. The statistical significance of these differences was calculated
with a standard t-test; the estimated difference in AUC statistics was divided by the standard
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error of that difference, as estimated with jackknife repeated replication. The resulting statistic
has a Student’s t distribution with degrees of freedom equal to the number of clusters in the
sample minus the number of strata, in this case 63-31=32 (Heeringa, West, and Berglund, 2010).
One overall analysis was conducted that included males and females of all races and
separate analyses were conducted for the three races with the largest sample size in NHANES,
non-Hispanic whites, non-Hispanic blacks, and Mexican Americans. All analyses were
conducted in the R statistical computing environment version 3.0.3 (R Core Team, 2014) with
the survey package (Lumley, 2012).

Chapter IV
RESULTS

4.1 Descriptive Statistics
Demographic characteristics, frequencies for the outcomes, and summary statistics for the
anthropometric measures are displayed in Table 2. All reported frequencies are unweighted.
There were 3,769 total observations in the study sample. This was reduced from 20,686 in the
total NHANES 2007-2010 sample. Many observations were removed from analysis because of
the 20-65 age restriction, but many more were removed because the fasting sub-sample with data
on fasting glucose and triglycerides was a small subset of the overall sample.
Forty-two percent (42%) of the sample was between the ages of 20 and 39, 45% was
between 40 and 59, and 13% was between 60 and 65. The sample was almost evenly split
between male (51%) and female (48%). Non-hispanic whites were the largest group (43%) and
the rest of the sample was approximately equal parts non-Hispanic black (19%), Mexican
American (21%), and other or multi-racial (17%).
High blood-pressure (33%), low HDL cholesterol (31%), and high triglycerides (29%)
were each present in about a third of the sample. High fasting glucose (48%) and the Metabolic
Syndrome (43%) were present in almost half of the sample. BMI ranged from about 15 kg/m2 to
about 85 kg/m2 with a mean of 29 kg/m2; WC ranged from about 59 cm to 167 cm with a mean
of 98 cm; and WHtR ranged from 0.37 to 1.03 with a mean of 0.58.

17

18

Table 2. Characteristics of Study Sample (n=3,769)
Variable
N
%
Minimum
Age
20-39
40-59
60-65
Sex
Male
Female
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other/Multi-Racial
High Blood Pressure
Yes
No
Low HDL
Yes
No
High Fasting Glucose
Yes
No
High Triglycerides
Yes
No
Metabolic Syndrome
Yes
No
BMI
WC
WHtR

1,594
1,697
478

42
45
13

1,833
1,936

51
48

1,612
720
791
646

43
19
21
17

1,232
2,537

33
67

1,170
2,599

31
69

1,826
1,943

48
52

1,079
2,690

29
71

1,616
2,153

43
57
15.02
59.10
0.37

Mean

Maximum

SD

29.00
98.14
0.58

84.87
167.00
1.03

6.69
15.99
0.10

*Frequencies are unweighted and are not representative of US population
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4.2 ROC Curves
All weighted, empirical ROC curves are presented in the Appendix. For the overall
sample and within each race subgroup, the diagnostic utility of WC, WHtR, and BMI are
compared for the Metabolic Syndrome and each component outcome. On the curve for BMI, the
cut points corresponding to a BMI of 25 and a BMI of 30 are indicated as a reference since these
are traditional BMI cut points for classifying overweight and obesity, respectively, and increased
cardiometabolic risk.

4.3 AUC Statistics
4.3.1 Overall
AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic
performance of WC and WHtR to BMI are reported in Table 3 for the entire sample (n=3,769).
WC performed better than BMI at classifying individuals with and without the Metabolic
Syndrome (p<0.001) and all of the component risk factors except for HDL cholesterol. WHtR
performed better than BMI at classifying Metabolic Syndrome (p=0.048), high blood pressure
(p=0.006), and high triglycerides (p=0.007). Neither WC nor WHtR performed better than BMI
at classifying low HDL cholesterol. WHtR performed no better than BMI at classifying high
fasting glucose.
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Table 3. AUC statistics and 95% Confidence Intervals, Overall (n=3,769)
AUC
Lower 95% CI Upper 95% CI
p
Blood Pressure
BMI
0.682
0.650
0.714
WC
0.703
0.675
0.731
0.001
WHtR
0.694
0.667
0.722
0.006
HDL Cholesterol
BMI
WC
WHtR

0.671
0.663
0.674

0.639
0.635
0.641

0.702
0.691
0.708

0.105
0.461

Fasting Glucose
BMI
WC
WHtR

0.664
0.698
0.674

0.634
0.667
0.645

0.695
0.728
0.703

<0.001
0.123

Triglycerides
BMI
WC
WHtR

0.656
0.677
0.676

0.632
0.654
0.652

0.679
0.699
0.700

0.001
0.007

Metabolic Syndrome
BMI
WC
WHtR

0.728
0.752
0.740

0.699
0.724
0.711

0.757
0.780
0.769

<0.001
0.048
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4.3.2 Non-Hispanic Whites
AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic
performance of WC and WHtR to BMI are reported in Table 4 for non-Hispanic whites
(n=1,612). Among non-Hispanic whites, WC performed better than BMI at classifying the
Metabolic Syndrome (p=0.038) and at classifying high fasting glucose (p<0.001). WC did
slightly better than BMI at classifying high blood pressure and high triglycerides and slightly
worse than BMI at classifying low HDL cholesterol, but none of these differences were quite
statistically significant at the 95% confidence level. WHtR was not significantly different from
BMI at classifying Metabolic Syndrome or any of the component risk factors.
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Table 4. AUC statistics and 95% Confidence Intervals, non-Hispanic whites (n=1,612)
AUC
Lower 95% CI Upper 95% CI
p
Blood Pressure
BMI
0.702
0.660
0.744
WC
0.716
0.678
0.754
0.079
WHtR
0.712
0.676
0.748
0.117
HDL Cholesterol
BMI
WC
WHtR

0.680
0.669
0.676

0.637
0.628
0.631

0.724
0.709
0.721

0.068
0.523

Fasting Glucose
BMI
WC
WHtR

0.675
0.707
0.680

0.632
0.665
0.639

0.718
0.749
0.721

<0.001
0.472

Triglycerides
BMI
WC
WHtR

0.670
0.683
0.685

0.634
0.647
0.649

0.706
0.719
0.721

0.081
0.148

0.742
0.757

0.701
0.717

0.783
0.797

0.038

0.744

0.703

0.784

0.830

Metabolic Syndrome
BMI
WC
WHtR
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4.3.3 Non-Hispanic Blacks
AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic
performance of WC and WHtR to BMI are reported in Table 5 for non-Hispanic blacks (n=720).
Among non-Hispanic blacks, WC performed better than BMI at classifying the Metabolic
Syndrome (p<0.001) and every component risk factor, except for low HDL cholesterol where a
slightly better performance was not statistically significant (p=0.090). WHtR was significantly
better than BMI at classifying Metabolic Syndrome (p<0.001), and every component risk factor
except for high triglycerides.
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Table 5. AUC statistics and 95% Confidence Intervals, non-Hispanic blacks (n=720)
AUC
Lower 95% CI Upper 95% CI
p
Blood Pressure
BMI
0.628
0.572
0.685
WC
0.666
0.608
0.724
<0.001
WHtR
0.659
0.603
0.715
0.002
HDL Cholesterol
BMI
WC
WHtR

0.662
0.679
0.688

0.598
0.626
0.634

0.726
0.733
0.741

0.090
0.043

Fasting Glucose
BMI
WC
WHtR

0.634
0.676
0.656

0.590
0.630
0.608

0.677
0.722
0.703

<0.001
0.009

Triglycerides
BMI
WC
WHtR

0.606
0.640
0.618

0.554
0.589
0.566

0.659
0.690
0.670

0.036
0.394

Metabolic Syndrome
BMI
WC
WHtR

0.705
0.748
0.739

0.671
0.715
0.705

0.738
0.781
0.773

<0.001
<0.001
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4.3.4 Mexican Americans
AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic
performance of WC and WHtR to BMI are reported in Table 6 for Mexican Americans (n=791).
Among Mexican Americans, WC performed better than BMI at classifying the Metabolic
Syndrome (p=0.001), high blood pressure (p<0.001), and high triglycerides (p=0.001). WC
performed significantly worse than BMI at classifying low HDL cholesterol (p=0.017) and
slightly better than BMI at classifying high fasting glucose, though this was not statistically
significant (p=0.061). WHtR was not statistically significantly different from BMI for Metabolic
Syndrome or any of the risk factors. The performance of WHtR was slightly better than BMI for
the Metabolic Syndrome (p=0.094), high blood pressure (p=0.055), and high triglycerides
(p=0.065), but none of these were quite statistically significant at the 95% confidence level.
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Table 6. AUC statistics and 95% Confidence Intervals, Mexican Americans (n=791)
AUC
Lower 95% CI Upper 95% CI
p
Blood Pressure
BMI
0.666
0.624
0.708
WC
0.713
0.672
0.753
<0.001
WHtR
0.694
0.658
0.730
0.055
HDL Cholesterol
BMI
WC
WHtR

0.687
0.665
0.679

0.648
0.621
0.641

0.726
0.708
0.717

0.017
0.375

Fasting Glucose
BMI
WC
WHtR

0.647
0.666
0.652

0.608
0.625
0.612

0.687
0.706
0.692

0.061
0.663

Triglycerides
BMI
WC
WHtR

0.639
0.669
0.659

0.596
0.636
0.617

0.681
0.702
0.701

0.001
0.065

Metabolic Syndrome
BMI
WC
WHtR

0.715
0.741
0.732

0.681
0.707
0.700

0.748
0.775
0.764

0.001
0.094

Chapter V
DISCUSSION AND CONCLUSION

In the complete sample, which is representative of the US adult population aged 20-65,
WC did a better job than BMI at classifying individuals with and without the Metabolic
Syndrome and all of the component risk factors except for HDL cholesterol. For HDL
cholesterol, there was no significant difference between WC and BMI. WC did a better job than
BMI at classifying individuals with and without the Metabolic Syndrome across all of the race
subgroups as well. The utility of WC in classifying the component risk factors varied a bit
between races. For the most part, WC performed better at classifying the component risk factors
among non-Hispanic blacks and Mexican Americans. However, among whites it only performed
better than BMI at classifying high fasting glucose. In summary, for every analysis in the overall
sample and in the race subgroups, WC performed significantly better than BMI or no different
from BMI, except for low HDL cholesterol among Mexican Americans where it performed
significantly worse than BMI.
WHtR performed significantly better than BMI at classifying individuals with and
without the Metabolic Syndrome in the entire sample and among non-Hispanic blacks. Among
non-Hispanic whites and Mexican Americans, WHtR was not significantly different from BMI at
classifying the Metabolic Syndrome. Results were mixed for the component risk factors. In the
full sample, WHtR performed better than BMI at classifying high blood pressure and high
triglycerides. Among non-Hispanic blacks, WHtR performed better than BMI at classifying high
blood pressure, low HDL cholesterol, and high fasting glucose. However, WHtR was not
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significantly different from BMI at classifying any of the risk factors among non-Hispanic
whites and Mexican Americans.
The results of this thesis differ slightly from the results of the meta-analysis by Ashwell
et al. (2012) who found that WHtR performed better than WC and BMI at classifying various
outcomes, including the Metabolic Syndrome, dyslipidemia, and hypertension. This metaanalysis reviewed 31 articles that used methods similar to the methods for this thesis and that
reported AUC statistics. However, out of the 31 studies included in the meta-analysis, only 2
were conducted in the US population and one of those only included women. The authors also
point out that before their meta-analysis it was difficult to prove the utility of WHtR over WC in
populations without a lot of variability in height and that 15 of the studies included the metaanalysis were conducted among Asian populations that tend to have shorter average heights.
Of the 2 studies conducted in the US and included in Ashwell et al.’s meta-analysis
(2012), one found that among US women WHtR and WC performed nearly identically at
classifying CVD and that both were superior to BMI (Page et al., 2009). This thesis reached
fairly similar conclusions, though the outcomes in this thesis were cardiometabolic risk factors
and not CVD itself and the sample in this thesis consisted of both men and women. The other
study, using an older sample of US adults from NHANES, did not compare WHtR and WC
directly but found that WHtR and WC performed similarly at classifying diabetes and that both
performed better than BMI (Li, Ford, Zhao, Kahn, & Mokdad, 2010). In contrast, this thesis
found that WC performed significantly better than BMI at classifying high fasting glucose while
WHtR did not. However, this thesis used a lower cut point to define high fasting glucose and
classified individuals who had been told by a doctor that they had diabetes and were taking
medication to lower their blood sugar as having high fasting glucose as well.
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The results of this thesis also differ with the meta-analysis of Lee et al. (2008) which
concluded that WHtR was the best anthropometric measure for classifying hypertension,
diabetes, and dyslipidemia. However, the 10 studies in the Lee et al. (2008) meta-analysis were
all included in the Ashwell et al. (2012) meta-analysis and none of them were conducted in the
US population.
The results of this thesis largely concur with the conclusions reached by Van Dijk et al.
(2012) in their meta-analysis. They reviewed articles that used different methods than this thesis
and examined the correlation coefficients between anthropometric measurements and risk factors
including high blood pressure, low HDL cholesterol, high triglycerides, and high fasting glucose.
Twenty studies were reviewed, including 4 of which were conducted in US populations. They
found that WC was more highly correlated with these risk factors than either WHtR or BMI.
The results of this thesis suggest that in a large, multi-ethnic, and nationally
representative sample of US adults aged 20-65, WC is superior to BMI at classifying the
Metabolic Syndrome as well as many of its component risk factors. This thesis did not explicitly
test the statistical significance of differences between WC and WHtR. However, WC performed
better than BMI more often than WHtR performed better than BMI across the outcomes and race
subgroups. In many cases, WC performed significantly better than BMI where WHtR did not.
In some cases, both WC and WHtR performed better than BMI but WC performed slightly
better. These results are also largely in agreement with similar studies conducted in the US
population. The few discrepancies between this thesis and previous research are likely due to
different study populations, different methods, and/or different outcome definitions. These
results also fit in with the current thinking that abdominal obesity is a stronger risk factor for the
Metabolic Syndrome than is body mass.
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When looking at the results for classifying the Metabolic Syndrome in the overall sample,
the differences between the AUC for BMI (0.728) and the AUCs for WC (0.752) and WHtR
(0.74) do not appear to be especially large, but it must be remembered that the ultimate utility of
using an anthropometric measure for classification depends on the cut point chosen for that
anthropometric measure. It is useful to examine the ROC curves and to consider a hypothetical
scenario to illustrate the magnitude of these differences. Using this sample, the weighted
estimate of the number of adults aged 20-65 with Metabolic Syndrome in the US between 2007
and 2010 is 67,296,904. Suppose a BMI of 25 (overweight) was used as a cut point to screen
this entire population so that individuals with a BMI of 25 or greater were then assessed for the
Metabolic Syndrome. This BMI cut point would result in a specificity of 0.442 and a sensitivity
of 0.863 and would identify 58,066,617 true positives. If WC was instead used for the screening
with a cut point of 89 cm, this would result in an almost identical specificity of 0.448 and a
sensitivity of 0.882 which would identify 59,373,231 true positives. Since the specificities are
nearly identical, the two measures would identify approximately the same amount of true
negatives, but WC would identify over 1.3 million more true positives than BMI.
Again, the selection of appropriate cut points will largely determine how exactly these
measures perform in practice, but the results of this thesis demonstrate that across the range of all
possible cut points, WC performs better than BMI. Currently, it is recommended that different
WC cut points be used in different populations and it is not entirely clear which cut points may
be optimal (Alberti et al., 2009). Further research should attempt to determine optimum WC cut
points for risk classification in the US population. The performance of these anthropometric
measures and the cut points that are chosen likely vary by sex as well. One limitation of this
thesis is that analyses were not conducted by sex in an effort to preserve large sample sizes. The
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clinical performance of WC would also of course depend on how WC is measured exactly and
whether or not patients will allow it. How to find and measure the waist is not always totally
clear. Measuring a patient’s WC is also slightly more invasive than measuring a patient’s BMI
in that it requires close physical contact from the physician. This may make certain patients less
willing to consent to measurement.
Of course, screening the entire adult US population to identify those at risk for the
Metabolic Syndrome would be difficult, so primary prevention for the Metabolic Syndrome,
CVD, and diabetes remains crucial. Public health must ensure that prevention efforts for these
diseases continue, especially in vulnerable populations. In the case of cardiovascular disease, the
American Heart Association has noted that primary and secondary prevention efforts are often
lacking in disadvantaged communities and has recommended the dissemination and
implementation of effective prevention strategies in these communities (Heidenreich et al.,
2011). Improving diagnostic screening tools to identify those with the Metabolic Syndrome and
at risk for CVD and diabetes can and should be a part of these primary and secondary prevention
strategies but will not alone be sufficient to control increasing prevalence of CVD and diabetes.
This thesis has shown that WC is a better screening tool than BMI for identifying
individuals at increased risk of the Metabolic Syndrome. WHtR also performs better than BMI
in many cases, though its performance is less consistent, especially across ethnicities. WHtR
also does not perform as well as WC at classifying high fasting glucose which is critical for
diabetes prevention efforts. WC should therefore be considered, over WHtR and especially over
BMI, for risk stratification in clinical settings and research in the US adult population.
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